Gum treatment study tracks key immune signals in mouth fluids
NCT ID NCT07307144
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at levels of two immune-related substances, fractalkine and CX3CR1, in the gum fluid of people with gingivitis or periodontitis. Researchers measured these before and after standard non-surgical gum treatment, like deep cleaning and oral hygiene advice. The goal was to understand how these markers change with treatment, not to test a new drug or cure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GINGIVITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Giresun University
Giresun, Turkey, 28100, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can smoking alter blood vessel proteins in your gums?
- Blood-Derived clot may regrow bone in gum disease
- Can gum disease be stopped by targeting these genes?
- Could saliva hold the key to understanding gum disease?
- Can a gentler Deep-Clean beat standard gum therapy?
- Could a toothpaste ingredient reshape the microbes behind gum disease?